statistiche ricercatore

NOONAN, DOUGLAS

Distribuzione geografica

Continente	#
NA - Nord America	26.878
EU - Europa	13.594
AS - Asia	7.952
SA - Sud America	1.048
Continente sconosciuto - Info sul continente non disponibili	361
AF - Africa	173
OC - Oceania	21
AN - Antartide	1
Totale	50.028

Salva come PNG Salva come JPEG

Nazione	#
US - Stati Uniti d'America	26.381
IT - Italia	6.968
SG - Singapore	2.661
UA - Ucraina	1.988
CN - Cina	1.659
VN - Vietnam	1.216
TR - Turchia	926
SE - Svezia	895
HK - Hong Kong	868
BR - Brasile	856
DE - Germania	763
FI - Finlandia	600
IE - Irlanda	600
GB - Regno Unito	568
FR - Francia	489
RU - Federazione Russa	306
CA - Canada	226
IN - India	128
BD - Bangladesh	125
MX - Messico	122
JP - Giappone	104
NL - Olanda	71
AR - Argentina	67
NG - Nigeria	64
ES - Italia	63
PL - Polonia	53
ZA - Sudafrica	41
IQ - Iraq	40
AT - Austria	39
BE - Belgio	39
ID - Indonesia	37
EU - Europa	35
JM - Giamaica	33
EC - Ecuador	32
CR - Costa Rica	31
CO - Colombia	22
CZ - Repubblica Ceca	22
HN - Honduras	22
LT - Lituania	20
UZ - Uzbekistan	19
VE - Venezuela	19
AE - Emirati Arabi Uniti	18
SA - Arabia Saudita	18
PK - Pakistan	17
PY - Paraguay	17
MA - Marocco	16
AU - Australia	15
CH - Svizzera	15
CL - Cile	14
PH - Filippine	13
TH - Thailandia	13
JO - Giordania	12
PT - Portogallo	12
TT - Trinidad e Tobago	11
KE - Kenya	10
TN - Tunisia	10
IL - Israele	9
MD - Moldavia	9
NP - Nepal	9
PE - Perù	9
SV - El Salvador	9
UY - Uruguay	9
EG - Egitto	8
KZ - Kazakistan	8
MY - Malesia	8
RO - Romania	8
DK - Danimarca	7
GT - Guatemala	7
LU - Lussemburgo	7
DZ - Algeria	6
EE - Estonia	6
GR - Grecia	6
LB - Libano	6
NZ - Nuova Zelanda	6
PR - Porto Rico	6
SC - Seychelles	6
AL - Albania	5
AZ - Azerbaigian	5
GP - Guadalupe	5
HU - Ungheria	5
KR - Corea	5
NI - Nicaragua	5
NO - Norvegia	5
A2 - ???statistics.table.value.countryCode.A2???	4
BB - Barbados	4
BY - Bielorussia	4
CW - ???statistics.table.value.countryCode.CW???	4
KG - Kirghizistan	4
PA - Panama	4
QA - Qatar	4
TW - Taiwan	4
BA - Bosnia-Erzegovina	3
BG - Bulgaria	3
BN - Brunei Darussalam	3
DO - Repubblica Dominicana	3
HR - Croazia	3
LY - Libia	3
RS - Serbia	3
AM - Armenia	2
AO - Angola	2
Totale	49.670

Salva come PNG Salva come JPEG

Città	#
Milan	4.600
Fairfield	2.686
Ashburn	2.406
San Jose	2.181
Woodbridge	1.790
Jacksonville	1.536
Singapore	1.422
Chandler	1.332
Houston	1.325
Seattle	1.110
Wilmington	980
Cambridge	922
Council Bluffs	875
Hong Kong	851
Ann Arbor	813
Dublin	594
Princeton	564
Dearborn	507
Dallas	492
Izmir	464
Nyköping	416
Boardman	394
Chicago	389
Beijing	371
Como	369
Rome	363
Dong Ket	334
The Dalles	326
Los Angeles	274
Lauterbourg	271
New York	252
Ho Chi Minh City	191
San Mateo	187
San Diego	180
Santa Clara	158
Hanoi	123
São Paulo	122
Helsinki	117
London	113
Munich	98
Ogden	88
Tokyo	88
Guangzhou	84
Buffalo	83
Orem	71
Washington	65
Abuja	63
Düsseldorf	62
Hefei	62
Mexico City	60
Phoenix	60
Montreal	59
Nanjing	59
Brooklyn	53
Kunming	53
Frankfurt am Main	47
Shanghai	46
Toronto	45
Warsaw	45
Salt Lake City	43
Chennai	41
Manchester	41
Atlanta	39
Turku	39
Jinan	38
Norwalk	38
Varese	38
Stockholm	37
Verona	37
Brussels	36
Da Nang	34
Denver	34
Ponte Lambro	34
San Francisco	34
Boston	32
Naples	32
Poplar	31
Tianjin	30
Johannesburg	28
Nuremberg	28
Falls Church	27
Elk Grove Village	25
Kocaeli	25
Nanchang	24
Vienna	24
Columbus	23
Amsterdam	22
Haiphong	22
Rio de Janeiro	22
Palermo	21
San José	21
Charlotte	20
Edinburgh	20
Magnago	20
Miami	20
Zhengzhou	20
Des Moines	19
Ankara	18
Baghdad	18
Berlin	18
Totale	34.864

Salva come PNG Salva come JPEG

Nome	#
A comparison between quantitative PCR and droplet digital PCR technologies for circulating microRNA quantification in human lung cancer	343
Angiogenin and the MMP9-TIMP2 axis are up-regulated in proangiogenic, decidual NK-like cells from patients with colorectal cancer	328
Polarization of Tumor Infiltrating Leukocytes from Innate Immunity and their role in the Pro-angiogenic Phenotype in NSCLC	322
Natural killer cells from patients with malignant or inflammatory pleural effusions display decreased cytotoxicity and decidual NK-like phenotype	292
Tumor inflammatory angiogenesis and its chemoprevention	289
Myeloid derived suppressor cells interactions with natural killer cells and pro-angiogenic activities: roles in tumor progression	278
Environmental impact of multi-wall carbon nanotubes in a novel model of exposure: Systemic distribution, macrophage accumulation, and amyloid deposition	277
Cancer stem cells and the tumor microenvironment: Interplay in tumor heterogeneity	271
Systematic review and critique of circulating miRNAs as biomarkers of stage I-II non-small cell lung cancer.	267
A think tank of TINK/TANKs: Tumor-infiltrating/tumor-associated natural killer cells in tumor progression and angiogenesis	258
Strategies to Prevent "bad Luck" in Cancer	256
Vitamin D Deficiency has a Negative Impact on Cetuximab-Mediated Cellular Cytotoxicity against Human Colon Carcinoma Cells	256
Acetyl-L-Carnitine downregulates invasion (CXCR4/CXCL12, MMP-9) and angiogenesis (VEGF, CXCL8) pathways in prostate cancer cells: rationale for prevention and interception strategies	250
Can the co-dependence of the immune system and angiogenesis facilitate pharmacological targeting of tumours?	248
Unsung hero Robert C. Gallo	247
Biomarkers of cancer angioprevention for clinical studies	246
Potential chemopreventive activities of a polyphenol rich purified extract from olive mill wastewater on colon cancer cells	244
Cardiovascular active peptides of marine origin with ACE inhibitory activities: Potential role as anti-hypertensive drugs and in prevention of SARSCoV-2 infection	244
Natural Killer Cells from Malignant Pleural Effusion Are Endowed with a Decidual-Like Proangiogenic Polarization	239
A single cis-acting element in a short promoter segment of the gene encoding the interphotoreceptor retinoid-binding protein confers tissue- specific expression	237
ANGIOGENIC POTENTIAL IN-VIVO BY KAPOSIS-SARCOMA CELL-FREE SUPERNATANTS AND HIV-1 TAT PRODUCT - INHIBITION OF KS-LIKE LESIONS BY TISSUE INHIBITOR OF METALLOPROTEINASE-2	236
Microenvironmental control of malignancy exerted by RNASET2, a widely conserved extracellular RNase.	235
Aspirin and atenolol enhance metformin activity against breast cancer by targeting both neoplastic and microenvironment cells	233
Natural killer cells from patients with either malignant or inflammatory pleural effusions display decreased cytotoxic capacity and decidual-like phenotype	233
Angiopoietin2 and tie2: tied to lymphangiogenesis and lung metastasis. New perspectives in antimetastatic antiangiogenic therapy	231
Immunomodulatory effect of vitamin D and its potential role in the prevention and treatment of thyroid autoimmunity: a narrative review	231
The proangiogenic phenotype of natural killer cells in patients with non-small cell lung cancer	230
Effect of a Purified Extract of Olive Mill Waste Water on Endothelial Cell Proliferation, Apoptosis, Migration and Capillary-Like Structure in vitro and in vivo.	230
Acetyl-L-carnitine is an anti-angiogenic agent targeting the VEGFR2 and CXCR4 pathways	230
T2 ribonuclease-mediated tumor suppression: an evolutionary conserved process involving a cross-talk between cancer cells and the immune system	230
Synthesis and antiangiogenic activity study of new hop chalcone Xanthohumol analogues	225
Systemic distribution of single-walled carbon nanotubes in a novel model: alteration of biochemical parameters, metabolic functions, liver accumulation, and inflammation in vivo	225
Angiogenesis and cancer prevention: a vision	224
Net amyloidogenic backbone in human activated neutrophils	220
Angioprevention with fenretinide: Targeting angiogenesis in prevention and therapeutic strategies.	218
Surface-activated chemical ionization-electrospray ionization source improves biomarker discovery with mass spectrometry	218
Endocrine disruptor agent nonyl phenol exerts an estrogen-like transcriptional activity on estrogen receptor positive breast cancer cells	217
Transgenic mice overexpressing arginase 1 in monocytic cell lineage are affected by lympho-myeloproliferative disorders and disseminated intravascular coagulation	217
SANIST: optimization of a technology for compound identification based on the European Union directive with applications in forensic, pharmaceutical and food analyses	216
Effects of IL-12 gene therapy on spontaneous transgenic and transplanted breast tumors	215
The human RNASET2 protein affects the polarization pattern of human macrophages in vitro	215
Microenvironment-mediated regulation of cancer growth by the human RNASET2 oncosuppressor gene	215
Proffered Paper: The pro-angiogenic phenotype of natural killer cells infiltrating squamous cell carcinoma lung cancer	214
Effects of 5-fluorouracil on morphology, cell cycle, proliferation, apoptosis, autophagy and ros production in endothelial cells and cardiomyocytes	214
Inflammatory angiogenesis and the tumor microenvironment as targets for cancer therapy and prevention	213
N-(4-hydroxyphenyl) retinamide inhibits retinoblastoma growth through reactive oxygen species-mediated cell death	212
AAV-mediated gene transfer of tissue inhibitor of metalloproteinases-1 inhibits vascular tumor growth and angiogenesis in vivo	211
Orchestration of angiogenesis by immune cells	209
The angiogenesis induced by HIV-1 Tat protein is mediated by the Flk-1/KDR receptor on vascular endothelial cells	207
Interactions of single-wall carbon nanotubes with endothelial cells.	206
Fenretinide (4-HPR) targets caspase-9, ERK 1/2 and the Wnt3a/β-catenin pathway in medulloblastoma cells and medulloblastoma cell spheroids	206
Tumor antagonizing genes and ovarian cancer: the role of the human RNASET2 gene.	205
SANIST: A rapid mass spectrometric SACI/ESI data acquisition and elaboration platform for verifying potential candidate biomarkers	205
Angiogenesis at the interface between basic and clinical research	204
The pro-angiogenic phenotype and functions of colorectal cancer tumour infiltrating (TINKs) and tumour associated (TANKs) natural killer cells	203
Prostate Cancer Peripheral Blood NK Cells Show Enhanced CD9, CD49a, CXCR4, CXCL8, MMP-9 Production and Secrete Monocyte-Recruiting and Polarizing Factors	202
Cell delivery of Met docking site peptides inhibit angiogenesis and vascular tumor growth	200
Cancer chemoprevention revisited: Cytochrome P450 family 1B1 as a target in the tumor and the microenvironment	200
Serum miR-223: a validated biomarker for detection of early-stage non-small cell lung cancer	200
Prediction of breast cancer metastasis by genomic profiling: where do we stand?	199
Cancer prevention by targeting angiogenesis	199
Contribution to tumor angiogenesis from innate immune cells within the tumor microenvironment: Implications for immunotherapy	199
Regulation of macrophage differentiation and polarization pattern by human RNASET2 protein	199
Prevention of angiogenesis by naked DNA IL-12 gene transfer: angioprevention by immunogene therapy	198
KSHV sequences in biopsies and cultured spindle cells of epidemic, iatrogenic and Mediterranean forms of Kaposi's sarcoma	197
Innate Immune Response Regulation by the Human RNASET2 Tumor Suppressor Gene	197
TRAIL inhibits angiogenesis stimulated by VEGF expression in human glioblastoma cells	197
The "chemoinvasion assay": a tool to study tumor and endothelial cell invasion of basement membranes	196
Angiostatin anti-angiogenesis requires IL-12: the innate immune system as a key target.	196
Galectin-1 suppression delineates a new strategy to inhibit myeloma-induced angiogenesis and tumoral growth in vivo	196
Suppression of autocrine and paracrine functions of basic fibroblast growth factor by stable expression of perlecan antisense cDNA	193
Kaposi's sarcoma cells of different etiologic origins respond to HIV-Tat through the flk-1/KDR (VEGFR-2): Relevance in AIDS-KS pathology	193
TREATMENT WITH A GLYCOSAMINOGLYCAN FORMULATION AMELIORATES EXPERIMENTAL DIABETIC NEPHROPATHY	192
Paradoxic effects of metformin on endothelial cells and angiogenesis.	191
Early DC and NK cell activation during anticancer therapeutic response induced by TNFa tumor vessel delivery and melphalan	191
Biosynthesis and structure of the basement membrane proteoglycan containing heparan sulphate side-chains	190
Anti-angiogenic activity of a novel class of chemopreventive compounds: oleanic acid terpenoids	190
Tumour infiltrating (TINKs) and tumour associated (TANKs) natural killer cells: a new paradigm in colorectal cancer angiogenesis	189
The synthetic oleanane triterpenoid, CDDO-methyl ester, is a potent antiangiogenic agent	187
RNASET2 as a tumor antagonizing gene in a melanoma cancer model	187
Neutrophils and angiogenesis: potential initiators of the angiogenic cascade	186
Multiple points of intervention in the prevention of cancer and other mutation-related diseases	186
Anti-KS activity still a mystery	185
Functional genomics of endothelial cells treated with anti-angiogenic or angiopreventive drugs	184
Cytokine Loaded Biopolymers as a Novel Strategy to Study Stem Cells during Wound Healing Processes.	184
The biguanides metformin and phenformin inhibit angiogenesis, local and metastatic growth of breast cancer by targeting both neoplastic and microenvironment cells	184
Kaposis sarcoma and human chorionic gonadotropin: Mechanisms, moieties and mysteries	183
Glycogen synthase kinase 3 regulates cell death and survival signaling in tumor cells under redox stress	182
Growth factors and chemokines: a comparative functional approach between invertebrates and vertebrates.	182
Surface activated chemical ionization - Electrospray mass spectrometry in the analysis of urinary thiodiglycolic acid	182
LAMININ-INDUCED RETINOBLASTOMA CELL-DIFFERENTIATION - POSSIBLE INVOLVEMENT OF A 100-KDA CELL-SURFACE LAMININ-BINDING PROTEIN	181
Exogenous hormonal regulation in breast cancer cells by phytoestrogens and endocrine disruptors.	181
The ovarian cancer tumor immune microenvironment (TIME) as target for therapy: a focus on innate immunity cells as therapeutic eﬀectors	181
INDUCTION OF A MALIGNANT PHENOTYPE IN BALB/C 3T3 CELLS BY 1,1,2,2-TETRACHLOROETHANE	180
Generation of biologically active angiostatin kringle 1-3 by activated human neutrophils	180
Activation of endothelial cell mitogen activated protein kinase ERK(1/2) by extracellular HIV-1 Tat protein	180
Angiostatin inhibits extracellular HIV-Tat-induced inflammatory angiogenesis	180
Cannabidiol inhibits angiogenesis by multiple mechanisms	180
MODULATION OF Y-79 RETINOBLASTOMA CELL-DIFFERENTIATION AND IRBP EXPRESSION BY DIBUTYRYL-CYCLIC-AMP AND LAMININ	179
The leech: a novel invertebrate model for studying muscle regeneration and diseases	179
Totale	21.562

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	199.396
article - articoli	0
book - libri	0
conference - conferenze	0
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	0
Totale	199.396

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	1.991	0	0	0	95	99	143	193	140	218	449	260	394
2022/2023	3.695	379	190	296	394	257	810	10	494	512	119	126	108
2023/2024	7.192	1.093	1.129	1.128	1.269	1.386	394	40	172	146	124	15	296
2024/2025	4.408	76	53	852	119	130	250	162	295	505	446	427	1.093
2025/2026	10.708	673	546	600	1.458	999	553	2.416	655	1.100	775	493	440
2026/2027	3.363	248	569	1.513	1.033	0	0	0	0	0	0	0	0
Totale													50.028